A pan cancer analysis showed that GLIS2 exhibited higher expression in pancreas cancer, colon cancer, breast cancer, and brain cancer, in comparison with their corresponding normal tissues (Fig. 6b), suggesting a wide oncogenic role in multiple cancers for GLIS2. This evidence concerns the gene GLIS2 and breast carcinoma.